Background: Soft tissue infections, including postoperative wound infections, result in a significant burden for modern society. Rapid diagnosis of wound infections is based on bacterial stains, cultures, and polymerase chain reaction assays, and the results are available earliest after several hours, but more often not until days after. Therefore, antibiotic treatment is often administered empirically without a specific diagnosis. Methods: We employed our electronic nose (eNose) system for this proof-of-concept study, aiming to differentiate the most relevant bacteria causing wound infections utilizing a set of clinical bacterial cultures on identical blood culture dishes, and established bacterial lines from the gaseous headspace. Results: Our eNose system was capable of differentiating both methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus pyogenes, Escherichia coli, Pseudomonas aeruginosa, and Clostridium perfringens with an accuracy of 78% within minutes without prior sample preparation. Most importantly, the system was capable of differentiating MRSA from MSSA with a sensitivity of 83%, a specificity of 100%, and an overall accuracy of 91%. Conclusions: Our results support the concept of rapid detection of the most relevant bacteria causing wound infections and ultimately differentiating MRSA from MSSA utilizing gaseous headspace sampling with an eNose.

Keywords:
Electronic nose, Methicillin-resistant Staphylococcus aureus, Point-of-care systems, Soft tissue infections, Wound infection
1.
Ellis Simonsen SM, van Orman ER, Hatch BE, Jones SS, Gren LH, Hegmann KT, Lyon JL: Cellulitis incidence in a defined population. Epidemiol Infect 2006; 134: 293–299.
2.
Dryden MS: Skin and soft tissue infection: microbiology and epidemiology. Int J Antimicrob Agents 2009; 34(suppl 1):S2–S7.
3.
Simonart T: Group a beta-haemolytic streptococcal necrotising fasciitis: early diagnosis and clinical features. Dermatology 2004; 208: 5–9.
4.
Kaide CG, Khandelwal S: Hyperbaric oxygen: applications in infectious disease. Emerg Med Clin North Am 2008; 26: 571–595, xi.
5.
Stevens DL, Aldape MJ, Bryant AE: Life-threatening clostridial infections. Anaerobe 2012; 18: 254–259.
6.
Sartelli M, Malangoni MA, May AK, Viale P, Kao LS, Catena F, Ansaloni L, Moore EE, Moore FA, Peitzman AB, Coimbra R, Leppaniemi A, Kluger Y, Biffl W, Koike K, Girardis M, Ordonez CA, Tavola M, Cainzos M, Di Saverio S, Fraga GP, Gerych I, Kelly MD, Taviloglu K, Wani I, Marwah S, Bala M, Ghnnam W, Shaikh N, Chiara O, Faro MP, Pereira GA, Gomes CA, Coccolini F, Tranà C, Corbella D, Brambillasca P, Cui Y, Segovia Lohse HA, Khokha V, Kok KY, Hong S, Yuan K: World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections. World J Emerg Surg 2014; 9: 57.
7.
Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC; Infectious Diseases Society of America: Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014; 59:e10–e52.
8.
Eagye KJ, Kim A, Laohavaleeson S, Kuti JL, Nicolau DP: Surgical site infections: does inadequate antibiotic therapy affect patient outcomes? Surg Infect (Larchmt) 2009; 10: 323–331.
9.
Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB, Bourbeau P, Carroll KC, Kehl SC, Dunne WM, Robinson-Dunn B, Schwartzman JD, Chapin KC, Snyder JW, Forbes BA, Patel R, Rosenblatt JE, Pritt BS: Executive summary: a guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis 2013; 57: 485–488.
10.
Caliendo AM, Gilbert DN, Ginocchio CC, Hanson KE, May L, Quinn TC, Tenover FC, Alland D, Blaschke AJ, Bonomo RA, Carroll KC, Ferraro MJ, Hirschhorn LR, Joseph WP, Karchmer T, MacIntyre AT, Reller LB, Jackson AF; Infectious Diseases Society of America (IDSA): Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis 2013; 57(suppl 3):S139–S170.
11.
Chang S, Hsieh W, Liu T, Lee S, Wang C, Chou H, Yeo YH, Tseng C, Lee C: Multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis – a systematic review and meta-analysis. PLoS One 2013; 8:e62323.
12.
Murray PR: What is new in clinical microbiology – microbial identification by MALDI-TOF mass spectrometry: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology. J Mol Diagn 2012; 14: 419–423.
13.
Roine A, Saviauk T, Kumpulainen P, Karjalainen M, Tuokko A, Aittoniemi J, Vuento R, Lekkala J, Lehtimäki T, Tammela TL, Oksala NKJ: Rapid and accurate detection of urinary pathogens by mobile IMS-based electronic nose: a proof-of-principle study. PLoS One 2014; 9:e114279.
14.
Yusuf N, Zakaria A, Omar MI, Shakaff AYM, Masnan MJ, Kamarudin LM, Abdul Rahim N, Zakaria NZI, Abdullah AA, Othman A, Yasin MS: In-vitro diagnosis of single and poly microbial species targeted for diabetic foot infection using e-nose technology. BMC Bioinformatics 2015; 16: 158.
15.
Utriainen M, Kärpänoja E, Paakkanen H: Combining miniaturized ion mobility spectrometer and metal oxide gas sensor for the fast detection of toxic chemical vapors. Sens Actuators B Chem 2003; 93: 17–24.
16.
Bishop CM: Pattern Recognition and Machine Learning. New York, Springer, 2006.
17.
Dutta R, Morgan D, Baker N, Gardner JW, Hines EL: Identification of Staphylococcus aureus infections in hospital environment: electronic nose based approach. Sens Actuators B Chem 2005; 109: 355–362.
18.
Dutta R, Hines EL, Gardner JW, Boilot P: Bacteria classification using Cyranose 320 electronic nose. Biomed Eng Online 2002; 1: 4.
19.
Dutta R, Dutta R: Intelligent Bayes Classifier (IBC) for ENT infection classification in hospital environment. Biomed Eng Online 2006; 5: 65.
20.
Kopp BJ, Nix DE, Armstrong EP: Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections. Ann Pharmacother 2004; 38: 1377–1382.
21.
Wilson AD, Baietto M: Advances in electronic-nose technologies developed for biomedical applications. Sensors (Basel) 2011; 11: 1105–1176.
22.
Thaler ER, Huang D, Giebeig L, Palmer J, Lee D, Hanson CW, Cohen N: Use of an electronic nose for detection of biofilms. Am J Rhinol 2008; 22: 29–33.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.